Garmin, Apollo Expand Tech-Driven Healthcare across India

The second chapter of Garmin India's strategic partnership with Apollo HealthAxis, a division of Apollo Hospitals, aims to enhance chronic illness management, health monitoring, and general wellbeing across India. The partnership has entered a new

FDA Approves Teva's First GLP-1 Drug for Obesity Treatment

Teva Pharmaceuticals, the U.S. affiliate of Teva Pharmaceutical Industries Ltd., has announced the FDA approval and U.S. market availability of the first generic version of Saxenda

MedGenome Unveils India's First Whole Genome Test for Brain Tumors

MedGenome unveiled the first CNS Tumour Methylation Classifier Test in India, which is a futuristic diagnostic tool that can recognize and categorize

GSK Enters India Oncology Market with Jemperli and Zejula Launch

GSK has made known the delivery of its cutting-edge oncology treatment Jemperli (dostarlimab) and Zejula (niraparib) in India, a considerable move to elevate the provision of precision cancer treatments.

Bayer's Gadoquatrane Drug Application Gains USFDA Review Approval

Bayer has announced that the U.S. Food and Drug Administration (FDA) has accepted its New Drug Application (NDA) for gadoquatrane, an investigational macrocyclic gadolinium-based contrast agent

AiMeD Warns GST Changes Could Affect India's Medical Devices Market

If not properly handled, shifting GST rates for medical equipment could affect domestic competitiveness, the Association of Indian medical Device Industry (AiMeD) said. The majority of devices are now subject to 12% GST, whilst inputs are subject to

Shilpa Medicare Expands with Saudi Arabia Joint Venture

Shilpa Medicare Limited has finalized a definitive agreement with Pharmaceutical Industries & Biological Products (PPI), a leading enterprise in Saudi Arabia, through its subsidiary Koanna International FZ LLC

Samsung Launches Next-Gen Mobile CT Solutions in India

The largest consumer electronics company in India, Samsung, has announced the arrival of its next-generation mobile CT product line in India in partnership with NeuroLogica, a division of Samsung Electronics Co., Ltd.

Biocon Pharma Wins Tentative USFDA Approval for Sitagliptin Medicine

Biocon has announced that its wholly owned subsidiary, Biocon Pharma Limited has received Tentative Approval from the United States Food and Drug Administration (USFDA)

FSSAI Eyes Menu Transparency With Sugar, Oil Disclosure Rule

The Food Safety and Standards Authority of India (FSSAI) is planning to release an advisory to restaurants and hotels to include labels in their outlets regarding key ingredients like sugar and oil in their dishes.

on the deck


Most Viewed

Editor's Guest


© 2025 India Pharma Outlook. All Rights Reserved.